Proteomics International Laboratories Ltd
ASX:PIQ

Watchlist Manager
Proteomics International Laboratories Ltd Logo
Proteomics International Laboratories Ltd
ASX:PIQ
Watchlist
Price: 0.66 AUD -1.49% Market Closed
Market Cap: 86.5m AUD
Have any thoughts about
Proteomics International Laboratories Ltd?
Write Note

Intrinsic Value

PIQ's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one PIQ stock under the Base Case scenario is 0.53 AUD. Compared to the current market price of 0.66 AUD, Proteomics International Laboratories Ltd is Overvalued by 20%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PIQ Intrinsic Value
0.53 AUD
Overvaluation 20%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Proteomics International Laboratories Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PIQ cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PIQ?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Proteomics International Laboratories Ltd

Provide an overview of the primary business activities
of Proteomics International Laboratories Ltd.

What unique competitive advantages
does Proteomics International Laboratories Ltd hold over its rivals?

What risks and challenges
does Proteomics International Laboratories Ltd face in the near future?

Has there been any significant insider trading activity
in Proteomics International Laboratories Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Proteomics International Laboratories Ltd.

Provide P/S
for Proteomics International Laboratories Ltd.

Provide P/E
for Proteomics International Laboratories Ltd.

Provide P/OCF
for Proteomics International Laboratories Ltd.

Provide P/FCFE
for Proteomics International Laboratories Ltd.

Provide P/B
for Proteomics International Laboratories Ltd.

Provide EV/S
for Proteomics International Laboratories Ltd.

Provide EV/GP
for Proteomics International Laboratories Ltd.

Provide EV/EBITDA
for Proteomics International Laboratories Ltd.

Provide EV/EBIT
for Proteomics International Laboratories Ltd.

Provide EV/OCF
for Proteomics International Laboratories Ltd.

Provide EV/FCFF
for Proteomics International Laboratories Ltd.

Provide EV/IC
for Proteomics International Laboratories Ltd.

Show me price targets
for Proteomics International Laboratories Ltd made by professional analysts.

What are the Revenue projections
for Proteomics International Laboratories Ltd?

How accurate were the past Revenue estimates
for Proteomics International Laboratories Ltd?

What are the Net Income projections
for Proteomics International Laboratories Ltd?

How accurate were the past Net Income estimates
for Proteomics International Laboratories Ltd?

What are the EPS projections
for Proteomics International Laboratories Ltd?

How accurate were the past EPS estimates
for Proteomics International Laboratories Ltd?

What are the EBIT projections
for Proteomics International Laboratories Ltd?

How accurate were the past EBIT estimates
for Proteomics International Laboratories Ltd?

Compare the revenue forecasts
for Proteomics International Laboratories Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Proteomics International Laboratories Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Proteomics International Laboratories Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Proteomics International Laboratories Ltd compared to its peers.

Compare the P/E ratios
of Proteomics International Laboratories Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Proteomics International Laboratories Ltd with its peers.

Analyze the financial leverage
of Proteomics International Laboratories Ltd compared to its main competitors.

Show all profitability ratios
for Proteomics International Laboratories Ltd.

Provide ROE
for Proteomics International Laboratories Ltd.

Provide ROA
for Proteomics International Laboratories Ltd.

Provide ROIC
for Proteomics International Laboratories Ltd.

Provide ROCE
for Proteomics International Laboratories Ltd.

Provide Gross Margin
for Proteomics International Laboratories Ltd.

Provide Operating Margin
for Proteomics International Laboratories Ltd.

Provide Net Margin
for Proteomics International Laboratories Ltd.

Provide FCF Margin
for Proteomics International Laboratories Ltd.

Show all solvency ratios
for Proteomics International Laboratories Ltd.

Provide D/E Ratio
for Proteomics International Laboratories Ltd.

Provide D/A Ratio
for Proteomics International Laboratories Ltd.

Provide Interest Coverage Ratio
for Proteomics International Laboratories Ltd.

Provide Altman Z-Score Ratio
for Proteomics International Laboratories Ltd.

Provide Quick Ratio
for Proteomics International Laboratories Ltd.

Provide Current Ratio
for Proteomics International Laboratories Ltd.

Provide Cash Ratio
for Proteomics International Laboratories Ltd.

What is the historical Revenue growth
over the last 5 years for Proteomics International Laboratories Ltd?

What is the historical Net Income growth
over the last 5 years for Proteomics International Laboratories Ltd?

What is the current Free Cash Flow
of Proteomics International Laboratories Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Proteomics International Laboratories Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Proteomics International Laboratories Ltd

Current Assets 9.2m
Cash & Short-Term Investments 6.6m
Receivables 269.3k
Other Current Assets 2.3m
Non-Current Assets 1.7m
PP&E 1.7m
Intangibles 1k
Current Liabilities 905k
Accounts Payable 57.6k
Other Current Liabilities 847.4k
Non-Current Liabilities 557.6k
Long-Term Debt 221k
Other Non-Current Liabilities 336.6k
Efficiency

Earnings Waterfall
Proteomics International Laboratories Ltd

Revenue
1.4m AUD
Operating Expenses
-7.9m AUD
Operating Income
-6.5m AUD
Other Expenses
74.7k AUD
Net Income
-6.4m AUD

Free Cash Flow Analysis
Proteomics International Laboratories Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PIQ Profitability Score
Profitability Due Diligence

Proteomics International Laboratories Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Negative 3-Years Revenue Growth
Negative 1-Year Revenue Growth
Declining ROE
19/100
Profitability
Score

Proteomics International Laboratories Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

PIQ Solvency Score
Solvency Due Diligence

Proteomics International Laboratories Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Proteomics International Laboratories Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PIQ Price Targets Summary
Proteomics International Laboratories Ltd

Wall Street analysts forecast PIQ stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PIQ is 0.51 AUD with a low forecast of 0.51 AUD and a high forecast of 0.53 AUD.

Lowest
Price Target
0.51 AUD
23% Downside
Average
Price Target
0.51 AUD
23% Downside
Highest
Price Target
0.53 AUD
20% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PIQ?

Click here to dive deeper.

Dividends

Proteomics International Laboratories Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for PIQ is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PIQ Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Proteomics International Laboratories Ltd Logo
Proteomics International Laboratories Ltd

Country

Australia

Industry

Life Sciences Tools & Services

Market Cap

86.4m AUD

Dividend Yield

0%

Description

Proteomics International Laboratories Ltd. is a medical technology company which operates at the forefront of predictive diagnostics and bio-analytical services. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2015-04-16. The firm is engaged in predictive diagnostics and bio-analytical services. The firm specializes in proteomics, the study of the structure and function of proteins. The firm focuses on developing and commercializing diagnostic tests for chronic diseases. The firm operates in three business units unified by a technology platform: PromarkerD, Diagnostics and Analytical Services. PromarkerD is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes. Diagnostics includes Promarker platform, used to discover, verify, and analytically validate the panel of protein biomarkers for diabetic kidney disease. Analytical Services includes proteomics-based technology platform, used to test, and validate the protein composition of a wide and varied range of products.

Contact

WESTERN AUSTRALIA
Nedlands
Harry Perkins Institute, 6 Verdun Street
+61893891992.0
www.proteomics.com.au

IPO

2015-04-16 00:00:00

Employees

-

Officers

Co-Founder, MD & Director
Dr. Richard John Lipscombe M.A., MA (Oxford), Ph.D., Ph.D., (London)
CFO & Head of Corporate Development
Ms. Jacqueline Gray
Head of Business Development
Mr. John Chuck Morrison
Head of Research
Dr. Scott Bringans
Head of Product Development
Dr. Pearl Tan
Head of Clinical Studies
Dr. Kirsten Peters
Show More
Company Secretary
Ms. Karen Teresa Logan ACIS, B.Com., BCom, DipAppCorpGov, F Fin, FCIS, FC
Show Less

See Also

Discover More
What is the Intrinsic Value of one PIQ stock?

The intrinsic value of one PIQ stock under the Base Case scenario is 0.53 AUD.

Is PIQ stock undervalued or overvalued?

Compared to the current market price of 0.66 AUD, Proteomics International Laboratories Ltd is Overvalued by 20%.

Back to Top